A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication (Q34646987)

3 August 2017

A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication (English)

1 reference

3 August 2017

1 reference

1 reference

6

Brigitte Autran

0 references

Agathe León

Agathe León

5

0 references

Javier Martinez-Picado

Javier Martínez-Picado

8

0 references

Felipe García

Felipe García

1

0 references

Bonaventura Clotet Sala

10

Bonaventura Clotet

1 reference

3 August 2017

7

Jeffrey D Lifson

1 reference

3 August 2017

11

Josep M Gatell

1 reference

3 August 2017

12

Montserrat Plana

1 reference

3 August 2017

Nuria Climent

2

1 reference

3 August 2017

Alberto C Guardo

3

1 reference

3 August 2017

Cristina Gil

4

1 reference

3 August 2017

Judit Dalmau

9

1 reference

3 August 2017

Teresa Gallart

13

1 reference

3 August 2017

DCV2/MANON07-ORVACS Study Group

14

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 January 2013

1 reference

Science Translational Medicine

3 August 2017

1 reference

3 August 2017

5

1 reference

3 August 2017

166ra2

1 reference

3 August 2017

166

1 reference

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

3 August 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Immunopathogenesis and immunotherapy in AIDS virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Therapeutic vaccines against HIV need international partnerships

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-ce

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Generation of specific Th1 and CD8+ T-cell responses by immunization with mouse CD8+ dendritic cells loaded with HIV-1 viral lysate or envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Therapeutic dendritic-cell vaccine for simian AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

A therapeutic dendritic cell-based vaccine for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004682

10.1126/SCITRANSLMED.3004682

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference